Summary of Diploma (DPLM.F) Trading Update - July 17, 2025 Company Overview - **Company**: Diploma (DPLM.F) - **Industry**: Aerospace, Defense, Energy, Life Sciences, Data Centers Key Performance Highlights - **Quarterly Performance**: Strong performance in Q3, contributing to a long-term track record of sustainable quality compounding [3][4] - **Organic Growth**: Upgraded organic growth forecast from 8% to 10% for the full year; year-to-date organic growth at 10% [3][4] - **Reported Revenue**: Year-to-date reported revenue growth of 12%, with 4% attributed to acquisitions, partially offset by foreign exchange effects [4] - **Operating Margins**: Operating margins remain strong, in line with full-year guidance of 22% [4] Acquisitions - **Recent Acquisitions**: - Acquired Parkinson for £11 million, a sealing solutions business to enhance existing operations in Denmark [5] - Acquired Alpha Laboratories for £28 million, entering high-growth IVD markets in the UK [5][6] - **Growth Expectations**: Expected high single-digit growth rates for both acquired businesses, contributing positively to future organic growth [11] - **Synergies**: Anticipated revenue synergies and cost efficiencies from the integration of acquired businesses into existing operations [12] Market Dynamics - **End Market Support**: Strong support in key markets such as aerospace, defense, and energy; positive trends observed in data centers [3][25] - **Industrial Market Trends**: Improvement noted in the US industrial markets, particularly in aftermarket sales; ongoing recovery in North American steel sector [20][34] - **Challenges in UK Market**: The UK industrial market remains challenging, particularly for seals, with ongoing efforts to improve the RNG business [34] Specific Business Performance - **Windy City Wire**: Performing well, particularly in data centers and digital antenna systems; consistent growth observed [24] - **Peerless**: Strong performance in aerospace, with continued revenue growth and high margins [36] - **Diksa**: Transitioning to professional management, with growth rates improving to mid-single digits [15] Additional Insights - **Acquisition Pipeline**: Long-term acquisition pipeline remains robust, with recent improvements in deal flow observed [20] - **Copper Price Volatility**: Current volatility in copper prices is being managed through pricing models, with expectations of pass-through costs [38][39] Conclusion - **Outlook**: Confidence in delivering sustainable quality compounding for the long term, with a positive view on future growth opportunities and market conditions [6][20]

Summary of M-tron Industries Inc (MPTI) FY Conference Call Company Overview - **Company Name**: M-tron Industries Inc (MPTI) - **Industry**: Defense Electronics, Specialty RF Components and Subsystems - **Ticker Symbol**: MPTI - **Recent Rebranding**: Formerly known as Emtron, celebrating 60 years in business [4][3] Core Business and Market Focus - **Primary Focus**: Defense electronics sector, specializing in RF components and subsystems [3] - **Manufacturing Locations**: Orlando, Florida, and Yankton, South Dakota, with some finishing in India [8][50] - **Customer Base**: Over 70 customers, many with long-term relationships exceeding ten years, including major players in aerospace and defense [9][51] Financial Performance - **Sales Performance**: Achieved $50 million in sales for the last year, with a gross margin of 46% and a backlog of $55.5 million [17] - **Growth Rates**: - Revenue CAGR over the past five years: 10% - Last three years: 20% [17][7] - **EBITDA Margins**: Consistently between 19% to 22% [18] - **Stock Performance**: Shares increased from approximately $10 at spin-off in late 2022 to around $45-$46, with a peak of $71 [10] Market Dynamics and Growth Drivers - **Market Segmentation**: - 56% from aerospace and defense - 25% from avionics - 5% from space and industrial sectors [19][20] - **Key Programs**: Engaged in significant missile programs, with annual orders contributing to long-term revenue streams [21][22] - **Emerging Markets**: Notable growth in drone technology and space applications, with increasing design wins [25][36] Competitive Advantages - **Vertical Integration**: Unique capability to manufacture components in-house, enhancing control over quality and costs [8][43] - **Engineering Expertise**: Strong team with extensive experience in RF engineering, allowing for tailored solutions and high customer satisfaction [6][12] - **Long-term Contracts**: Focus on high-margin, non-commodity markets with loyal customers [30] Challenges and Risks - **Tariff Impacts**: Subject to tariffs on imported materials, with ongoing efforts to mitigate costs through negotiations with defense customers [63][65] - **Market Volatility**: Potential impacts from geopolitical tensions and military budget discussions affecting defense spending [34] Future Outlook - **Growth Strategy**: Plans to achieve consistent 10% revenue growth through organic and inorganic means, including potential acquisitions [67] - **Investment in Technology**: Continuous upgrades and automation in manufacturing processes to enhance capacity and efficiency [32][33] - **Market Trends**: Anticipated growth in defense spending due to replenishment needs and modernization of military capabilities [34][35] Conclusion M-tron Industries Inc is well-positioned in the defense electronics sector with a strong financial performance, a loyal customer base, and significant growth opportunities in emerging markets. The company’s focus on vertical integration and engineering expertise provides a competitive edge, although it must navigate challenges related to tariffs and market volatility.

Financial Data and Key Metrics Changes - Fourth quarter sales reached $438 million, a 5.8% increase year-over-year, driven by strong performance in the Aerospace and Defense (A&D) segment and industrial businesses [4][5] - Consolidated gross margin for the quarter was 44.2%, up from 43.1% in the same period last year [4] - Adjusted diluted EPS was $2.83, representing a 14.6% increase from $2.47 a year ago [4][15] - Total A&D sales grew by 10.6% year-over-year, with commercial aerospace up 11.6% and defense up 8.2% [5][6] - For the full year, A&D sales grew by 14%, with commercial aerospace up 13.3% and defense up 15.9% [6] Business Line Data and Key Metrics Changes - The industrial segment grew by 3.3% year-over-year, with distribution and aftermarket up 2.5% and OEM up 5.1% [5][7] - Industrial gross margins were reported at 45.7%, while A&D margins were at 41.5% [14][36] - The Dodge business experienced double-digit OEM sales growth for the full year, reflecting successful organic growth initiatives [8][10] Market Data and Key Metrics Changes - The commercial aerospace market is expected to grow by at least 15%, driven by production growth at Boeing and Airbus [9][10] - The defense sector is anticipated to grow in the mid- to high single digits, supported by a proposed $1 trillion defense budget [10][11] - Industrial markets are more challenging to predict due to factors like interest rates and tariffs, but MRO demand remains steady [10] Company Strategy and Development Direction - The company is focused on leveraging core strengths in engineering, manufacturing, and product development to drive both organic and inorganic growth [18] - There is a strong emphasis on continuous improvement in operating efficiency and high levels of free cash flow conversion [18] - The company plans to reinvest some margin expansion into future growth through investments in SG&A [17] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism for fiscal 2026, expecting strong growth across all channels [11][12] - The company is well-positioned to pursue additional accretive M&A, with a focus on maintaining a healthy balance sheet [11][18] - Management acknowledged challenges in the industrial economy but highlighted strong performance relative to peers [7][10] Other Important Information - The company allocated $275 million to debt repayment in fiscal 2025, reducing trailing net leverage to 1.7 turns [11][16] - Free cash flow for the quarter was $55 million, with a conversion rate of 76% [15][16] - The company expects CapEx to be in the range of 3% to 3.5% of sales for the upcoming year [17][54] Q&A Session Summary Question: Commercial aerospace production rates and revenue potential - Management expects Boeing to reach 38 planes per month soon, with potential for upper 40s production rates by early 2026, which could significantly increase revenue [26][27] Question: Industrial growth initiatives and sustainability - Management highlighted improvements in service levels and new product introductions as key drivers of growth, with a healthy outlook for sustaining leadership in growth [30][32] Question: Gross margins by segment and expansion potential - Industrial gross margins were 45.7% and A&D was 41.5%, with management indicating potential for further expansion in A&D margins [36][38] Question: Tariff impacts and supply chain considerations - Management remains neutral on short-term tariff impacts but sees potential long-term benefits from increased tariffs [42][44] Question: Capacity and growth flexibility - Management noted that some plants are overloaded with demand, and they are actively adding labor and machinery to meet growth needs [51][52] Question: M&A pipeline and strategic focus - Management is actively exploring M&A opportunities, focusing on candidates that align with their operational strengths and customer relationships [75][82]

Financial Data and Key Metrics Changes - Revenue for Q1 2025 was $4.5 million, a decrease of approximately 23% compared to $5.8 million in Q1 2024, primarily due to the discontinuation of TrustCo's operations and a softening of customer shipments [4][12] - Gross profit decreased by $800,000 to $1.5 million in Q1 2025 from $2.3 million in Q1 2024, with gross margin at 33% compared to 39% in the prior year [12][13] - Operating expenses were reduced by approximately 28% to $2.1 million in Q1 2025 from $2.9 million in Q1 2024, helping to offset the decrease in gross margin [5][13] - The net loss for the quarter was $600,000, or a loss of $0.05 per diluted share, consistent with Q1 2024 [13] Business Line Data and Key Metrics Changes - The decline in revenue was most pronounced in premium services, which were down 47% compared to the same quarter last year [4] - Improvements in gross margin were noted in proactive services within the Precision Logistics segment, which is viewed as a key area for organic growth [5] Market Data and Key Metrics Changes - The overall market environment remains challenging, with a noted softening in customer demand across several proactive customers, particularly in e-commerce [46] - New customer additions have slowed down, and existing customers are experiencing a softening in demand, impacting overall revenue [45][46] Company Strategy and Development Direction - The company is focusing on three elements for organic growth: optimizing direct customer marketing and sales, developing relationships with additional freight carriers, and integrating with technology platforms related to e-commerce [7][9] - Strategic growth efforts include pursuing transformative and tuck-in acquisitions, leveraging the strong balance sheet and cash flow to create shareholder value [10][49] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the current macroeconomic challenges but remains optimistic about the company's ability to create shareholder value through strategic initiatives and a strong cash position [6][54] - The company is focused on maximizing upside opportunities in a changing logistics marketplace, which is becoming more receptive to new ideas and partnerships [55][56] Other Important Information - The company had a cash balance of $5.7 million at the end of Q1 2025, with no bank debt and only $800,000 remaining on convertible notes held by insiders [6][14] - Nancy Meyers, the CFO, announced her retirement, with Jennifer Colo set to take over the role [16][19] Q&A Session Summary Question: What are the capital allocation priorities moving forward? - The company is prioritizing organic growth investments funded by business operations, with a focus on integrating with e-commerce platforms and expanding customer relationships [24][26] Question: What is the revenue generation for the authentication business in the quarter? - The revenue for the authentication business was $26,000 [31] Question: Should revenue comparisons be expected to improve in the second half of the year? - Revenue comparisons are expected to remain challenging in Q2, with hopes for improvement in the second half of the year [35][38] Question: How are new customers performing and what is the outlook for existing customers? - New customer additions have slowed, and existing customers are experiencing a softening in demand, impacting overall revenue [45][46] Question: What is the latest update on the ink business and strategic discussions? - The company is exploring potential acquisitions that could synergize with its ink business, but the focus remains on opportunities within Precision Logistics [49]

Financial Data and Key Metrics Changes - Ambac generated $318 million in premium, up 70%, and $63 million in revenue, up 27% from the prior year [6][12] - The net loss from continuing operations was $16 million or $0.58 per share, compared to a loss of $4 million or $0.09 per share in the same quarter last year [12] - Adjusted EBITDA from continuing operations was a loss of $1 million compared to a slight profit in the first quarter of 2024 [13] Business Line Data and Key Metrics Changes - The distribution business segment, Serata, generated over $230 million in premium for the quarter, up 156% [6] - Everspan's gross premiums written were approximately $87 million, down 10% from the prior year [10] - Dorado revenue increased by 129% to $41 million, driven primarily by the acquisition of B Capital [14] Market Data and Key Metrics Changes - Organic growth, excluding the Beat acquisition, contracted by 2%, but would have been almost 12% without the pullback in ESL and short-term medical business [7] - Everspan's loss ratio improved to 66.9% from 75.7% in the prior year [15] - The combined ratio for Everspan was 102.1%, up from 98.4% last year [16] Company Strategy and Development Direction - The company aims to maintain profitable underwriting results and expand its specialty P&C business, focusing on organic and inorganic growth [8][17] - Ambac plans to generate $80 million to $90 million of adjusted EBITDA for common shareholders by 2028 [18] - The company is enhancing risk capacity, product expansion, and distribution to drive synergies across its platform [9] Management's Comments on Operating Environment and Future Outlook - Management believes market conditions are stabilizing and turning favorable for growth despite challenges in ESL [8] - The company is focused on building a long-term business model that resonates in the specialty MGA and delegated authority program space [17] - Management sees significant opportunities for staffing growth and attracting top talent in the current market [20] Other Important Information - The OCI approval process for the sale of the legacy business is ongoing, which is expected to transform Ambac into a pure play specialty P&C insurance business [11] - The increase in total expenses was driven by a $21 million increase in general and administrative expenses related to the acquisition of Beat [13] Q&A Session Summary Question: Importance of staffing to top line growth and market conditions for recruiting - Management emphasized that staffing is crucial for individual MGAs and that there are significant opportunities for staffing growth due to the attractiveness of their business model [20][21] Question: Update on property versus casualty mix and growth outlook - Management indicated that liability will be the primary source of growth, while property remains attractive despite softening prices [22][23] Question: Comments on the competitive environment - Management acknowledged growing competition but believes their unique business model and capacity relationships allow them to attract top talent [25]

Financial Data and Key Metrics Changes - In Q1 2025, revenue was $77.3 million, representing a decrease of 4% year over year [22] - Reported gross profit declined by 5% year over year, with consumer payment segment gross profit also down by 5%, while business payment segment gross profit increased by 77% year over year [22] - Adjusted EBITDA for Q1 was $33.2 million, maintaining an adjusted EBITDA margin of approximately 43% [23] - Reported free cash flow was negative $8 million, impacted by client losses and working capital changes, but excluding these impacts, free cash flow conversion would have been similar to 38% in Q1 2024 [24] Business Line Data and Key Metrics Changes - Consumer payments showed core growth with contributions from existing clients and new client wins, despite client losses impacting reported growth [8][12] - Business payments reported a gross profit increase of approximately 7% year over year, with a normalized growth of about 12% when excluding political media contributions from the previous year [13][22] - Instant funding product in value-added services saw transaction volumes rise approximately 19% year over year [11] Market Data and Key Metrics Changes - Non-discretionary consumer spending remained resilient year to date, with no major impacts observed from macroeconomic factors [9][52] - The company signed two new software partnerships in consumer payments, increasing total software partners to 182 [10] Company Strategy and Development Direction - The company concluded its strategic review process, focusing on organic growth investments rather than M&A, believing this will yield the best results for shareholders [16][17] - Key operational priorities include enhancing the direct sales model, capitalizing on monetization opportunities, and building indirect partnership channels [17] - The company aims for sequential quarterly normalized gross profit growth, projecting high single-digit to low double-digit growth by Q4 2025 [18] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to invest organically and produce results that generate shareholder value, with expectations for growth acceleration in the second half of 2025 [18][19] - The macroeconomic environment has changed, but the company remains focused on profitable growth and cash flow generation [16][19] Other Important Information - The Board of Directors increased the share repurchase program authorization to $75 million, maintaining a strong balance sheet with ample liquidity [19][25] - Tim Murphy, the CFO, will be stepping down, with Thomas Sullivan appointed as interim CFO [20][19] Q&A Session Summary Question: Can you provide additional color on the consumer spending environment? - Management noted resiliency in non-discretionary consumer spending, with no major impacts from overall payment processing related to macroeconomic factors [29] Question: Given the increased buyback authorization, do you plan to continue leaning into this rather than M&A? - Management confirmed that they will opportunistically repurchase shares when the share price is disconnected from intrinsic value, while focusing on organic growth [30][31] Question: How far did you go down the strategic review process? - The company assessed various strategic alternatives but concluded that additional investment in organic growth would yield the best results for shareholders [34] Question: Can you help us think about the EBITDA growth trajectory over 2025? - Management indicated that adjusted EBITDA growth would follow a similar path as gross profit growth, with no incremental spend beyond what has been forecasted [38] Question: What are you seeing in terms of repayment volume health in the auto vertical? - Management reported strength in nondiscretionary spending in the auto sector, with no specific issues observed [77]

Financial Data and Key Metrics Changes - In Q1 2025, revenue was $77.3 million, representing a decrease of 4% year over year [19] - Reported gross profit declined by 5% year over year, with consumer payment segment gross profit also down by 5%, while business payment segment gross profit increased by 77% year over year [19] - Adjusted EBITDA for Q1 was $33.2 million, reflecting approximately 43% adjusted EBITDA margins [21] - Reported free cash flow was negative $8 million, impacted by client losses and working capital changes [22] - As of March 31, the company had approximately $165 million in cash and access to $250 million in undrawn revolver capacity, totaling $415 million in liquidity [23] Business Line Data and Key Metrics Changes - Consumer payments showed core growth with contributions from existing clients and new client wins, despite client losses impacting reported growth [6][10] - Business payments reported a gross profit increase of approximately 7% year over year, with a normalized growth of about 12% when excluding political media contributions from the previous year [11][19] - The company signed two new software partnerships in consumer payments, increasing total software partners to 182 [8] Market Data and Key Metrics Changes - The company noted resiliency in non-discretionary consumer spending year to date, despite economic unpredictability [7] - The sales pipeline for enterprise clients remains healthy, with ongoing efforts to enhance payment capabilities [7][8] Company Strategy and Development Direction - The company concluded its strategic review process, focusing on organic growth investments as the best way to create shareholder value [13][14] - Key operational priorities include enhancing the direct sales model, capitalizing on monetization opportunities, and building indirect partnership channels [15] - The company aims for sequential quarterly normalized gross profit growth, targeting high single-digit to low double-digit growth by Q4 2025 [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability to invest organically and produce results that generate shareholder value [16] - The company anticipates free cash flow conversion exceeding 50% in Q2 and accelerating above 60% by year-end, excluding one-time impacts [22] - Management acknowledged the ongoing macroeconomic uncertainties but emphasized the strength of their business model and value proposition [7][10] Other Important Information - The company announced an increase in its share repurchase program authorization to $75 million [17] - Tim Murphy, the CFO, will be stepping down, with Thomas Sullivan appointed as interim CFO [18] Q&A Session Summary Question: Can you provide additional color on the consumer spending environment? - Management noted resiliency in non-discretionary consumer spending year to date, with no major impacts from overall payment processing related to macroeconomic factors [26][27] Question: Given the increased buyback authorization, do you plan to focus more on this rather than M&A? - Management confirmed that they will opportunistically repurchase shares when they believe the share price is disconnected from intrinsic value, while still focusing on organic growth [28][30] Question: How far did you go down the strategic review process? - Management indicated that the decision to conclude the review was based on the belief that additional investment in organic growth would yield the best results for shareholders [33][34] Question: Can you discuss the EBITDA growth trajectory for 2025? - Management expects adjusted EBITDA growth to follow a similar path as gross profit growth, with no incremental spend beyond what has been forecasted [36] Question: What are the trends in the auto vertical? - Management reported strength in nondiscretionary spending within the auto vertical, with no significant changes observed in client dynamics [75]

Financial Data and Key Metrics Changes - The company reported total organic growth of 6% in Q1, at the top end of previous guidance [6] - Adjusted EBITDA was $215 million with a margin of 17.2%, exceeding the high end of Q1 guidance due to strong execution [7] - Earnings per share (EPS) was $1.62, reflecting benefits from share repurchases and a planned increase in the tax rate [7] - Free cash flow conversion was 40%, highlighting progress on accounts receivable collections [7] Business Line Data and Key Metrics Changes - ATM Managed Services and Digital Retail Solutions (AMS DRS) grew over 20% for the fourth consecutive quarter, now representing a quarter of total business [6][8] - Cash and Valuables Management (CVM) grew 1% organically, with strong performance in Global Services contributing to overall growth [18] - The Global Services business saw elevated precious metal movement, leading to improved year-over-year growth [8] Market Data and Key Metrics Changes - North America experienced constant currency growth of 4% and organic growth of 2%, with DRS growth highlighted by new customer onboarding [13] - Latin America reported 7% organic growth, but this was offset by currency devaluation, particularly in Mexico and Argentina [14] - Europe grew revenue by 5% organically, with AMS DRS mix increasing to 42% of total revenue [15] Company Strategy and Development Direction - The company is focused on maximizing growth potential in AMS DRS, expanding margins, and executing a capital allocation framework [7][10] - The strategy includes increasing network density and improving routing flexibility to support profit margin expansion [25] - The company is exploring accretive M&A opportunities that align with its capital allocation framework [31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience amid economic uncertainty, citing a diversified global footprint and strong customer relationships [24][25] - The outlook for the second quarter includes expectations for continued mid-single-digit organic growth and EBITDA between $200 million and $225 million [10][34] - Management remains cautious about the Global Services business due to slowing growth trends observed in early Q2 [19] Other Important Information - The company repurchased 1.3 million shares at an average price of $87.62, representing about 3% of outstanding shares [9] - A third consecutive annual increase in the quarterly dividend was announced, reflecting a commitment to shareholder returns [9][31] Q&A Session Summary Question: Can you talk about your tariff exposure? - Management indicated no significant direct exposure to tariffs, as most costs and revenues are in the same currency and services are not heavily imported [39][40] Question: Can you discuss pricing trends in Latin America? - Management confirmed that pricing strategies are in place to offset currency devaluations, particularly in highly inflationary markets like Argentina [42][43] Question: What are the drivers for the second quarter margin guidance? - Key drivers include FX impacts, interest income from Argentina, and restructuring actions, with expectations for improved margins in the second half of the year [50][51][55] Question: What is the expected impact of interest income on EBITDA for the full year? - Management expects a headwind of approximately $4 million to $5 million per quarter from reduced interest income [56] Question: What are the growth expectations excluding last year's equipment sales? - Management anticipates continued growth trajectory in DRS AMS, despite a couple of points of headwind from last year's equipment sales [62][63] Question: Why is AMS DRS expected to be more resilient to macro softness? - The larger white space and subscription-based revenue model of AMS DRS provide more consistent revenues compared to traditional CIT business [70][71]

Financial Data and Key Metrics Changes - Brink's reported total organic growth of 6% in Q1, at the top end of previous guidance [6] - Adjusted EBITDA was $215 million with a margin of 17.2%, exceeding the high end of Q1 guidance [7] - Earnings per share (EPS) was $1.62, reflecting benefits from share repurchases and a planned increase in the tax rate [7] - Free cash flow conversion was 40%, highlighting progress on accounts receivable collections [7][11] Business Line Data and Key Metrics Changes - ATM Managed Services and Digital Retail Solutions (AMS DRS) grew over 20% for the fourth consecutive quarter, now representing a quarter of total business [6][8] - Cash and Valuables Management (CVM) grew 1% organically, with strong performance in Global Services [18] - Global Services revenue increased due to elevated precious metal movement, particularly in the Rest of World segment [8][17] Market Data and Key Metrics Changes - North America saw constant currency growth of 4% and organic growth of 2%, with DRS growth highlighted by new customer onboarding [14] - Latin America experienced 7% organic growth, but was negatively impacted by currency devaluation, particularly in Mexico and Argentina [15] - Europe grew revenue by 5% organically, with AMS DRS mix increasing to 42% of total revenue [16] Company Strategy and Development Direction - The company continues to focus on maximizing growth potential in AMS DRS, expanding margins, and executing a focused capital allocation framework [7][11] - Share repurchases and dividend increases are part of the capital allocation strategy, with remaining repurchase capacity of over $180 million [10][32] - The company is well-positioned to capture elevated demand and is exploring accretive M&A opportunities [9][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to navigate uncertain macroeconomic conditions, citing a diversified global footprint and strong customer relationships [25][26] - The outlook for the second quarter includes expectations for continued mid-single-digit organic growth and EBITDA between $200 million and $225 million [11][37] - Management remains cautious about the Global Services business due to slowing growth in early Q2 but is optimistic about capturing future opportunities [20][38] Other Important Information - The company repurchased 1.3 million shares at an average price of $87.62, representing about 3% of outstanding shares at year-end 2024 [9][10] - Adjusted EBITDA margins were down 50 basis points year-over-year, impacted by regional revenue mix and less interest income from Argentina [28] Q&A Session Summary Question: Can you talk about your tariff exposure? - Management indicated minimal direct exposure to tariffs, as most costs and revenues are in the same currency and services are not heavily imported [41][42] Question: Can you discuss pricing trends in Latin America? - Management confirmed that pricing strategies are in place to offset currency devaluations, particularly in highly inflationary markets like Argentina [44][45] Question: What are the drivers for the second quarter margin guidance? - Key drivers include FX impacts, Argentina interest income, and restructuring actions, with expectations for improved margins in the second half of the year [51][52][56] Question: How do you expect AMS DRS growth to perform in a softer macro environment? - Management noted that the larger addressable market and subscription-based revenue model of AMS DRS provide resilience against economic downturns [70][72] Question: What trends are observed in the BGS segment post-Q1? - Management reported a slowdown in shipment volumes in April compared to Q1, with expectations for mid-single-digit organic growth moving forward [75][76]

Financial Data and Key Metrics Changes - The company reported total revenue of $1.4 billion, reflecting a 4% growth on a reported basis and 1% organic growth, with organic growth excluding $148 million from CSL and the whole blood divestiture at 8% [7][8] - Adjusted gross margin for the fourth quarter was 60.2%, an increase of 620 basis points compared to the prior year, driven by volume growth and improved product mix [24][25] - Adjusted net income for fiscal year 2025 was $231.5 million, up $28 million or 14%, with adjusted earnings per diluted share at $4.57, a 15% increase compared to the prior year [29] Business Line Data and Key Metrics Changes - Hospital revenue grew 12% in the quarter and 24% in fiscal year 2025 on a reported basis, with organic growth of 9% respectively [11] - Blood Management Technologies revenue grew 6% in the quarter and 10% in fiscal year 2025, driven by strong utilization and share gains [11] - The Interventional Technologies franchise delivered 21% reported growth in the quarter and 46% in fiscal year 2025, with 16% organic growth respectively [13] Market Data and Key Metrics Changes - Plasma revenue declined 9% in the quarter and 6% in fiscal year 2025, but excluding CSL, plasma revenue grew 11% in the fourth quarter and 5% for fiscal year 2025 [18][20] - Blood center revenue declined 22% in the quarter and 8% in fiscal year 2025 on a reported basis due to the whole blood divestiture [21] - The company anticipates plasma revenue to decline 7% to 10% on a reported basis in fiscal year 2026, with organic growth excluding CSL expected to be 11% to 14% [20] Company Strategy and Development Direction - The company is focused on advancing its innovation agenda and reallocating resources towards higher growth opportunities following the divestiture of the whole blood business [28] - A new regional and market alignment initiative is expected to generate approximately $30 million of net savings over the next two years [28] - The company aims for both blood management technologies and interventional technologies to become billion-dollar franchises each [66] Management's Comments on Operating Environment and Future Outlook - Management remains confident in the strong growth trajectory of the hospital business, projecting reported and organic revenue growth of 8% to 11% in fiscal year 2026 [16] - The company expects adjusted operating margin to improve by 200 to 300 basis points, reaching 26% to 27% in fiscal year 2026 [33] - Management highlighted the importance of cash flow generation and expects free cash flow in fiscal year 2026 to be in the range of $160 million to $200 million [35] Other Important Information - The company executed a $150 million share buyback, repurchasing approximately 2.4 million shares, reflecting its commitment to value creation [10] - The adjusted income tax rate was 22% for the fourth quarter and 23% for fiscal year 2025, compared to 21% to 23% for the respective periods of the prior year [28] Q&A Session Summary Question: Insights on plasma collections and guidance for fiscal year 2026 - Management remains bullish on plasma, indicating that the 11% to 14% growth guidance is primarily driven by share gains and technology adoption, with modest growth expected in the first half of fiscal year 2026 [43][45] Question: Clarification on EPS guidance and operating margin drivers - The operating margin guidance of 26% to 27% is supported by continued gross margin improvement and operational leverage, with a $0.20 impact from tariffs factored into the guidance [47][49] Question: Update on vascular closure portfolio and legacy business performance - The company is focusing on driving utilization and share gains in the vascular closure market, with a dedicated team addressing both new and legacy products [55][60] Question: Changes in strategy following management transitions - The leadership changes are aimed at enhancing focus on growth in the hospital segment, with expectations for both blood management and interventional technologies to reach billion-dollar franchises [66][67] Question: Update on M&A activities and potential acquisition of VIVUSURE Medical - The company maintains a long-term appetite for strategic acquisitions, with optimism regarding the VIVUSURE opportunity, which aligns with its focus on closure and structural heart segments [74][76]